An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration

NCT02591914 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-Related Macular Degeneration

Interventions

DRUG: Fovista™
DRUG: Lucentis®
DRUG: Avastin®
DRUG: Eylea®

Sponsor

Retinal Consultants of Arizona

Collaborators

[object Object]